1. Home
  2. TCRX vs KBSX Comparison

TCRX vs KBSX Comparison

Compare TCRX & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

N/A

Current Price

$0.24

Market Cap

49.4M

Sector

Health Care

ML Signal

N/A

Logo FST Corp. Ordinary Shares

KBSX

FST Corp. Ordinary Shares

N/A

Current Price

$1.59

Market Cap

50.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
TCRX
KBSX
Founded
2018
1976
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
49.4M
50.6M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
TCRX
KBSX
Price
$0.24
$1.59
Analyst Decision
Hold
Analyst Count
5
0
Target Price
★ $1.00
N/A
AVG Volume (30 Days)
★ 761.4K
40.0K
Earning Date
11-11-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 12.28
N/A
EPS
N/A
★ N/A
Revenue
★ $10,325,000.00
N/A
Revenue This Year
N/A
$18.93
Revenue Next Year
N/A
$13.80
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 266.65
N/A
52 Week Low
$0.22
$0.81
52 Week High
$2.57
$1.79

Technical Indicators

Market Signals
Indicator
TCRX
KBSX
Relative Strength Index (RSI) 24.14 52.79
Support Level N/A $1.11
Resistance Level $0.37 $1.68
Average True Range (ATR) 0.03 0.17
MACD 0.01 -0.01
Stochastic Oscillator 12.62 47.69

Price Performance

Historical Comparison
TCRX
KBSX

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

Share on Social Networks: